Research Article
Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury
Table 2
Lipid profile, glucose profile, ectopic adipose tissue, and inflammation in persons with motor complete SCI.
| | Total, n = 22 | Tetra, n = 8 | Para, n = 14 |
| Lipid profile | | | | Total cholesterol (mg/dl) | 150.1 ± 29.0 | 160.4 ± 21.1 | 144.3 ± 31.9 | TG (mg/dl) | 111.1 ± 54.5 | 141.1 ± 68.2 | 93.9 ± 37.6 | LDL-C (mg/dl) | 92.6 ± 26.9 | 98.4 ± 23.2 | 89.3 ± 29.1 | HDL-C (mg/dl) | 35.0 ± 8.1 | 33.0 ± 6.5 | 36.1 ± 8.9 | Non-HDL-C (mg/dl) | 111.9 ± 32.3 | 127.4 ± 16.7 | | Total cholesterol: HDL-C | 4.4 ± 1.0 | 4.9 ± 0.7 | | FFA (µM/L) | 363.7 ± 188.8 | 394.1 ± 216.6 | 346.3 ± 177.2 | Metabolic profile | | | | Fasting glucose (mg/dl) | 107.1 ± 13.0, = 21 | 114.5 ± 14.54 | 102.5 ± 9.8, = | ((mU/L)−1 min−1) | 8.62 ± 6.28, = 19 | 4.61 ± 6.07, n = 6 | 10.47 ± 5.67, = | (min−1) | 0.020 ± 0.009 | 0.017 ± 0.003 | 0.022 ± 0.011 | HbA1c (%) | 5.35 ± 0.45, = 21 | 5.61 ± 0.50 | 5.19 ± 0.34, = | Testosterone (ng/dl) | 424.4 ± 159.1 | 345.3 ± 125.5 | | SAT and VAT | | | | Trunk CSA (cm2) | 654.4 ± 139.6 | 664.7 ± 166.8 | 648.5 ± 128.0 | SAT (cm2) | 157.0 ± 79.6 | 163.5 ± 103.2 | 153.4 ± 66.7 | VAT (cm2)
| 105.4 ± 63.9
| 117.5 ± 57.2
| 98.4 ± 68.6
| Inflammation | | | | TNFα (pg/ml) | 15.3 ± 8.0 | 16.0 ± 8.2 | 14.9 ± 8.1 | IL-6 (pg/ml)
| 5.89 ± 6.77
| 5.03 ± 5.39
| 6.39 ± 7.59
| Liver analysis () | 20 | 7 | 13 | FSF (%) | 3.73 ± 2.10 | 5.34 ± 2.05 | | Liver CSA (cm2) | 163.4 ± 31.8 | 158.0 ± 30.5 | 166.3 ± 33.4 |
|
|
Values are means ± SD; , number of participants; Tetra, tetraplegic; Para, paraplegic; LDL, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FFA, free-fatty acids; , insulin sensitivity; , glucose effectiveness; HbA1c, glycated hemoglobin; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; TNFα, tumor necrosis factor alpha; IL-6, interleukin-6; FSF, fat signal fraction; CSA, cross-sectional area; , tetra versus para.
|